Buenavista leads a €15 million funding round in Highlight Therapeutics

by Buenavista Equity Partners

Buenavista Equity Partners, through its specialized fund BV Healthcare Growth Innvierte I (BHG I) created in collaboration with Columbus Venture Partners, has announced its entry into the shareholding...

Read more

Highlight Therapeutics, a portfolio company of Columbus Venture Partners, and the CNIO launch their seventh clinical trial in advanced skin cancer

by Columbus Venture Partners

The Columbus Venture Partners team, strategic investor in the development of BO-112, celebrates this new clinical milestone as a validation of the company’s scientific and business strategy, while a...

Read more

Highlight Therapeutics levanta una ronda de €22,6 millones con la participación de Columbus Venture Partners, Advent Life Science y el CDTI

by CDTI Innovación

El Fondo Español Columbus Life Science y el inglés Advent Life Science han liderado una ronda de inversión de 22,6 millones de euros en la empresa biotecnológica Highlight Therapeutics, que ha con...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

The Worst Business in the World That Eve...

by Bondo Advisors

Football clubs trade at absurd multiples, private equity funds keep pa...

Photos Stream